Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

Stratum corneum

Also known as: stratum corneum, horny layer, corneocyte layer

The stratum corneum is the outermost epidermal layer: flattened, anucleate corneocytes joined by corneodesmosomes and embedded in organised extracellular lipids. Its thickness and composition vary by body site. It is the principal physical substrate of permeability-barrier function, but it is anatomy, not every barrier process.

Evidence status

Strong

Core anatomy, lipid organisation and regional variation are well established. Exact turnover, hydration and desquamation values depend on site and method, and no primary source establishing a universal 28-day replacement interval was located.

What it is#

The stratum corneum is the outermost epidermal layer: flattened, anucleate corneocytes joined by corneodesmosomes and embedded in organised extracellular lipids.[1, 2, 3]

It is the principal physical permeability barrier — and it is not a synonym for “the skin barrier”, which also covers chemical, immune and antimicrobial functions that are not purely structural.[1, 2, 3]

This entry is the anatomy. The function it supports, the way that function is measured, and what happens when it fails are covered separately — linked under Related entries.

Bricks and mortar#

The familiar analogy is corneocytes as bricks and lipids as mortar. It is a good one as long as you remember that the mortar is doing most of the barrier work, and that it is highly organised rather than simply filling gaps.

Corneocytes, their cornified envelopes and the extracellular lipid lamellae together form a two-compartment structure central to permeability-barrier function.[1, 3]

The lipids themselves — ceramides, cholesterol and free fatty acids — have their own entry. Ex-vivo human epidermal analysis identified glucosylceramides as major precursors of the stratum-corneum ceramides.[5]

The matrix is active#

It is tempting to think of this layer as dead cells waiting to fall off. That is wrong in a way that matters clinically.

The extracellular matrix contains lipids, enzymes, structural proteins and antimicrobial peptides — it is a functioning compartment, not packaging.[3]

Which is the honest argument against aggressive over-exfoliation: removing this layer is not removing debris, it is removing a working structure that has to be rebuilt.

It varies by site#

There is no single stratum corneum. In normal-skin sections from 301 people, mean corneocyte-layer counts varied substantially by anatomical site: 6±2 layers at genital skin, 47±24 at palms and soles, and 86±36 at the heel.[4]

Layers, not micrometres. That study counted corneocyte layers; it did not measure physical thickness, and it tested no treatment protocol. Layer count and thickness are related and they are not interchangeable, and neither one sets a peel depth, a needle depth or a device parameter. Site variation is a good reason to treat the neck differently from the cheek. It is not a number you can dial in.

Hydration varies the same way. A meta-analysis of healthy-adult corneometry found stratum-corneum hydration to be site-dependent rather than a single normal value.[8]

The practical consequence is one most protocols ignore: a peel depth, a needle depth or an exfoliation frequency that is appropriate on the cheek is not automatically appropriate on the eyelid, the neck or the back.

How it sheds#

Corneocytes are held together by corneodesmosomes, and shedding requires those to be broken down. The proposed mechanism involves kallikrein enzymes.

In an acidic in-vitro enzyme system, KLK5 and KLK7 cleaved different corneodesmosomal proteins.[6]

Note what that is: a laboratory model of how desquamation may be regulated, using purified or recombinant proteins in a controlled system. It is a good mechanistic account, and it is not a measurement of what happens in living skin.

This is also where the “skin pH controls shedding” argument comes from — those enzymes are pH-sensitive. That reasoning is covered in the skin-barrier entry, where the pH evidence properly belongs.

The 28-day problem#

Almost every training course teaches that skin renews itself every 28 days. We went looking for the primary evidence and did not find it.[no source found]

What does exist is a classic kinetic study calculating a 39-daymean epidermal transit time — built from mixed human, literature and xenograft inputs. A later reanalysis of the same data, splitting the epidermis into proliferative, differentiated and stratum-corneum compartments, calculated 47 to 48 days instead.[7, 9]

Three things follow, and all three matter in a consultation:

  • The best-known figure is 39, not 28.
  • It is a model output, not a stopwatch reading — calculated from assumptions, some of them from animal xenografts.
  • It describes the whole epidermis, not the stratum corneum alone.
  • Two credible calculations from one dataset differ by more than a week.

And none of them is a results timetable. How long a treatment takes to show a result depends on the treatment and on the endpoint you are measuring; a modelled transit time cannot answer that question, whichever number you pick.[7, 9]So 28 days is unsourced, 39 days is a model output, 47 to 48 days is a different model output from the same data — and “roughly a month” is not the safe compromise it looks like, because it is still a promise about results built from a number about cell transit.

In professional practice#

  • Treat the site, not the face. Layer count and hydration vary substantially across the body.
  • Respect the matrix. It is a functioning compartment containing enzymes and antimicrobial peptides, not dead packaging.
  • Retire the turnover timetable altogether.Do not replace 28 days with 39 or with “roughly a month”. Set expectations from the treatment and the endpoint, and say that cell transit is a different question nobody has settled either.[7, 9]
  • Don’t equate this layer with the barrier. It is the substrate; barrier function is broader.

What remains uncertain#

  • Actual stratum-corneum-specific turnover time, as distinct from whole-epidermal transit.
  • How closely the in-vitro desquamation model reflects enzyme activity in living skin.
  • How much of the site-to-site variation is thickness and how much is lipid composition.
  • Whether any of the commonly quoted turnover figures vary meaningfully with age, and by how much.

Common misconceptions#

“Skin renews every 28 days.”

No primary source for 28 was located.[no source found] The classic figure is 39 days — a model, of whole-epidermis transit — and a reanalysis of the same dataset calculated 47 to 48 days.[7, 9] None of the three tells you when a treatment will work.[7, 9]

“The stratum corneum is dead skin.”

The cells are anucleate, but the matrix around them contains active enzymes, structural proteins and antimicrobial peptides.[3]

“The stratum corneum is the skin barrier.”

It is the principal physical permeability barrier — one part of a broader set of functions.[1, 2, 3]

“It’s the same thickness everywhere.”

Layer counts varied substantially by site across 301 people.[4]

Frequently asked questions#

How long does it really take to see results?

Longer than 28 days, and it varies. The best-known model gives 39 days for whole-epidermal transit, and it is a calculation rather than a measurement. “Roughly a month, give or take” is the defensible version.[7, 9]

Why does the same peel behave differently on the neck?

Because the stratum corneum is not the same thickness there. Corneocyte layer counts vary substantially by site.[4]

Is exfoliating just removing dead cells?

You are removing a functioning compartment that contains enzymes and antimicrobial peptides, which then has to be rebuilt. That is the real argument against over-exfoliation.[3]

What actually makes cells shed?

Breakdown of corneodesmosomes, with kallikrein enzymes implicated — demonstrated in a controlled laboratory system rather than measured in living skin.[6]

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. Madison KC. Barrier function of the skin: 'la raison d'être' of the epidermis. Journal of Investigative Dermatology. 2003;121(2):231–241.Tier 4Supports: Core stratum-corneum anatomy and its role as the principal permeability barrier.
  2. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Experimental Dermatology. 2008;17(12):1063–1072.Tier 4Supports: The stratum corneum within the wider set of skin barrier functions — physical, chemical, immune and antimicrobial.
  3. Elias PM. Structure and function of the stratum corneum extracellular matrix. Journal of Investigative Dermatology. 2012;132(9):2131–2133.Tier 4Supports: The two-compartment corneocyte-and-lipid model, and the extracellular matrix as an active compartment containing enzymes, structural proteins and antimicrobial peptides.Funding / interest: Peter Elias is a leading commercial proponent of the physiologic-lipid school this source is cited to support, and is a named inventor on the EpiCeram patent. The published conflict statement is paywalled and has not been read here.
  4. Ya-Xian Z, Suetake T, Tagami H. Number of cell layers of the stratum corneum in normal skin — relationship to the anatomical location on the body, age, sex and physical parameters. Archives of Dermatological Research. 1999;291(10):555–559.Tier 3Supports: Normal-skin sections from 301 people. Mean corneocyte-layer counts varied by site, from around 6±2 at genital skin to substantially more at the palm and sole.
  5. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. Journal of Investigative Dermatology. 2002;119(2):416–423.Ex vivoTier 3Supports: Ex-vivo human epidermal analysis identifying glucosylceramides as major precursors of stratum-corneum ceramides. NOTE: donor provenance details are not in the accessible record and the full text is blocked, so no donor age range, tissue source or post-collection interval is stated here.
  6. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. Journal of Investigative Dermatology. 2004;122(5):1235–1244.In vitroTier 3Supports: In an acidic in-vitro enzyme system, KLK5 and KLK7 cleaved different purified or recombinant corneodesmosomal proteins — a laboratory model of desquamation, not a measurement in living skin.Funding / interest: Author affiliations include L'Oréal (Centre Charles Zviak, Clichy).
  7. Weinstein GD, McCullough JL, Ross P. Cell proliferation in normal epidermis. Journal of Investigative Dermatology. 1984;82(6):623–628.Animal studyTier 3Supports: A classic whole-epidermis kinetic model calculating a 39-day mean transit time from mixed human, literature and xenograft inputs. It is a model, not a measured clock, and it concerns the whole epidermis rather than the stratum corneum alone.
  8. Samadi A, Yazdanparast T, Shamsipour M, et al. Stratum corneum hydration in healthy adult humans according to the anatomical site: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2022;36(11):1993–2002.Tier 1Supports: Meta-analysis of healthy-adult corneometry showing site-dependent stratum-corneum hydration, with pooled values differing markedly between body sites.
  9. Iizuka H. Epidermal turnover time. Journal of Dermatological Science. 1994;8(3):215–217.Tier 3Supports: A REANALYSIS OF THE SAME DATA, verbatim: 'Using Weinstein's data (J Invest Dermatol 82: 623-628, 1984), the epidermal turnover time was calculated to be 47-48 days instead of 39 days.' It subdivides the epidermis into proliferative, differentiated and stratum-corneum compartments and sums their turnover times. Registered here because two credible calculations from one dataset differ by more than a week — which is the reason no turnover figure can supply a results timetable.